Zajicek J - Search Results

1

The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.

Ball S, Vickery J, Hobart J, Wright D, Green C, Shearer J, Nunn A, Cano MG, MacManus D, Miller D, Mallik S, Zajicek J. Ball S, et al. Among authors: zajicek j. Health Technol Assess. 2015 Feb;19(12):vii-viii, xxv-xxxi, 1-187. doi: 10.3310/hta19120. Health Technol Assess. 2015. PMID: 25676540 Free PMC article. Clinical Trial.

2

Central nervous system sarcoidosis--diagnosis and management.

Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, Scadding JW, Thompson EJ, Chamoun V, Miller DH, McDonald WI, Mitchell D. Zajicek JP, et al. QJM. 1999 Feb;92(2):103-17. doi: 10.1093/qjmed/92.2.103. QJM. 1999. PMID: 10209662

3

Cannabinoids on trial for multiple sclerosis.

Zajicek J. Zajicek J. Lancet Neurol. 2002 Jul;1(3):147. doi: 10.1016/s1474-4422(02)00068-6. Lancet Neurol. 2002. PMID: 12849481 Review. No abstract available.

4

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.

Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A; UK MS Research Group. Zajicek J, et al. Lancet. 2003 Nov 8;362(9395):1517-26. doi: 10.1016/S0140-6736(03)14738-1. Lancet. 2003. PMID: 14615106 Clinical Trial.

5

The effect of cannabis on tremor in patients with multiple sclerosis.

Fox P, Bain PG, Glickman S, Carroll C, Zajicek J. Fox P, et al. Among authors: zajicek j. Neurology. 2004 Apr 13;62(7):1105-9. doi: 10.1212/01.wnl.0000118203.67138.3e. Neurology. 2004. PMID: 15079008 Clinical Trial.

6

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

Carroll CB, Bain PG, Teare L, Liu X, Joint C, Wroath C, Parkin SG, Fox P, Wright D, Hobart J, Zajicek JP. Carroll CB, et al. Among authors: zajicek jp. Neurology. 2004 Oct 12;63(7):1245-50. doi: 10.1212/01.wnl.0000140288.48796.8e. Neurology. 2004. PMID: 15477546 Clinical Trial.

7

The use of cannabinoids in multiple sclerosis.

Teare L, Zajicek J. Teare L, et al. Among authors: zajicek j. Expert Opin Investig Drugs. 2005 Jul;14(7):859-69. doi: 10.1517/13543784.14.7.859. Expert Opin Investig Drugs. 2005. PMID: 16022575 Review.

8

Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88).

Hobart JC, Riazi A, Thompson AJ, Styles IM, Ingram W, Vickery PJ, Warner M, Fox PJ, Zajicek JP. Hobart JC, et al. Among authors: zajicek jp. Brain. 2006 Jan;129(Pt 1):224-34. doi: 10.1093/brain/awh675. Epub 2005 Nov 9. Brain. 2006. PMID: 16280352

9

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.

Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ, Thompson AJ. Zajicek JP, et al. J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1664-9. doi: 10.1136/jnnp.2005.070136. J Neurol Neurosurg Psychiatry. 2005. PMID: 16291891 Free PMC article. Clinical Trial.

10

The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS).

Freeman RM, Adekanmi O, Waterfield MR, Waterfield AE, Wright D, Zajicek J. Freeman RM, et al. Among authors: zajicek j. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Nov;17(6):636-41. doi: 10.1007/s00192-006-0086-x. Epub 2006 Mar 22. Int Urogynecol J Pelvic Floor Dysfunct. 2006. PMID: 16552618 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page